16-51591-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000293860.6(POLR3K):c.166G>T(p.Ala56Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,614,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000293860.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLR3K | NM_016310.5 | c.166G>T | p.Ala56Ser | missense_variant | 2/3 | ENST00000293860.6 | NP_057394.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLR3K | ENST00000293860.6 | c.166G>T | p.Ala56Ser | missense_variant | 2/3 | 1 | NM_016310.5 | ENSP00000293860 | P1 | |
POLR3K | ENST00000481810.1 | n.552G>T | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251434Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135900
GnomAD4 exome AF: 0.000109 AC: 159AN: 1461816Hom.: 0 Cov.: 30 AF XY: 0.000114 AC XY: 83AN XY: 727206
GnomAD4 genome AF: 0.000151 AC: 23AN: 152362Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.166G>T (p.A56S) alteration is located in exon 2 (coding exon 2) of the POLR3K gene. This alteration results from a G to T substitution at nucleotide position 166, causing the alanine (A) at amino acid position 56 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at